Login / Signup

Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: FOR: Optimising reproductive outcomes is cost-effective and minimises adverse sequelae.

Jara Ben NagiPaul SerhalDagan WellsBenjamin P Jones
Published in: BJOG : an international journal of obstetrics and gynaecology (2019)
Keyphrases
  • polycystic ovary syndrome
  • genome wide
  • pregnancy outcomes
  • copy number
  • cervical cancer screening
  • breast cancer risk
  • gene expression
  • type diabetes
  • pregnant women
  • adverse drug
  • weight loss
  • electronic health record